Hosted on MSN1d
Regeneron CEO: We have 40 drugs in development
In an interview on CNBC’s Mad Money, Len Schleifer said Regeneron (REGN) currently has 40 drugs in development representing billions in potential ...
Cramer's Lightning Round: Super Micro Computer is a sell
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Cramer's Lightning Round: 'I do not dig RIG'
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Cramer’s Mad Dash: Lululemon
With turquoise waters, vibrant marine life, and a laid-back feel, Caye Caulker is perfect for your next beach vacation.
TipRanks on MSN1d
Merck CEO: We’re a much broader company than we have been
In an interview on CNBC’s Mad Money, Robert Davis said Merck’s (MRK) current pipeline is the most diversified it has been in recent history.
Cramer's Lightning Round: Arbutus Biopharma is 'the ultimate spec'
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Cramer's Mad Dash: Cornell report on GLP-1s shows decrease in consumption of savory snacks
Cramer's Mad Dash: Cornell report on GLP-1s shows decrease in consumption of savory snacks Aftermath of command post in ...
Cramer's Mad Dash: Advanced Micro
'Mad Money' host Jim Cramer looks at Nvidia's latest unveiling and what is ahead for the company in 2025.